Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. adenovirus vector
Show results for
Products
Services

Companies

News
Articles

Refine by
Date

  • Older

Adenovirus Vector Articles & Analysis

4 news found

Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Creative Diagnostics Announces Antiviral Drug Discovery Services to Accelerate Therapeutic Development

Target identification and validation Creative Diagnostics' integrated approach to target identification and validation harnesses the vast potential of large data sets, computational tools and therapeutic expertise to generate breakthrough hypotheses that drive the drug discovery process. By combining multiple viral vector technologies, including adenovirus, and ...

ByCreative Diagnostics


(Viral) Vaccine Manufacturing

(Viral) Vaccine Manufacturing

Multiple vaccine types, such as DNA-, RNA-based formulations, subunits containing viral epitopes, adenovirus-based vectors and inactivated whole viruses are under development. ...

ByNuvonis


PsiOxus and bluebird bio Present Novel Data Combining PsiOxus T-SIGn Platform with CAR-T Therapy to Clear Primary Tumors and Metastases

PsiOxus and bluebird bio Present Novel Data Combining PsiOxus T-SIGn Platform with CAR-T Therapy to Clear Primary Tumors and Metastases

Single IV cycle of PsiOxus’ T-SIGn vector enabled an otherwise non-effective dose of CAR-T cell therapy to clear primary and metastatic tumors in vivo Reprogramming of the tumor microenvironment using T-SIGn vectors could enable a variety of CAR-T therapies to overcome limitations in solid tumors Data is currently being presented at the AACR Virtual ...

ByPsiOxus Therapeutics Ltd.


PsiOxus Therapeutics updates agreement with Bristol-Myers Squibb to advance their clinical stage immuno-oncology collaboration

PsiOxus Therapeutics updates agreement with Bristol-Myers Squibb to advance their clinical stage immuno-oncology collaboration

NG-641, is a tumor re-engineering product using PsiOxus’ proprietary Tumor-Specific Immuno-Gene Therapy (T-SIGn) platform based upon the enadenotucirev vector. NG- 641 is a systemically administered product that encodes for the tumor selective delivery of an anti-FAP/anti-CD3 bispecific, interferon alpha, CXCL9 and CXCL10. ...

ByPsiOxus Therapeutics Ltd.

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT